$334 Million is the total value of Integral Health Asset Management, LLC's 60 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 60.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $9,867,000 | +6.2% | 80,000 | -27.3% | 2.96% | -27.8% |
| CCXI | Sell | CHEMOCENTRYX INC | $8,631,000 | +13.1% | 150,000 | -21.1% | 2.58% | -23.1% |
| DHR | Sell | DANAHER CORPORATION | $7,957,000 | +15.0% | 45,000 | -10.0% | 2.38% | -21.8% |
| CTLT | Sell | CATALENT INC | $7,330,000 | -5.9% | 100,000 | -33.3% | 2.20% | -36.1% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $6,611,000 | -22.1% | 125,000 | -34.2% | 1.98% | -47.0% |
| MRK | Sell | MERCK & CO. INC | $5,800,000 | -42.0% | 75,000 | -42.3% | 1.74% | -60.6% |
| EXAS | Sell | EXACT SCIENCES CORP | $4,782,000 | +3.1% | 55,000 | -31.2% | 1.43% | -29.9% |
| PKI | Sell | PERKINELMER INC | $2,943,000 | -13.1% | 30,000 | -33.3% | 0.88% | -41.0% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $2,794,000 | -17.8% | 110,000 | -40.5% | 0.84% | -44.1% |
| FATE | Sell | FATE THERAPEUTICS INC | $2,402,000 | +13.8% | 70,000 | -26.3% | 0.72% | -22.6% |
| WBA | Sell | WALGREENS BOOTS ALLIANCE INC | $1,696,000 | -53.7% | 40,000 | -50.0% | 0.51% | -68.5% |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $1,421,000 | -26.0% | 75,000 | -25.0% | 0.43% | -49.6% |
| BMYRT | Sell | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $537,000 | -68.6% | 150,000 | -66.7% | 0.16% | -78.6% |
| PFNX | Exit | PFENEX INC | $0 | – | -85,000 | -100.0% | -0.33% | – |
| Exit | AMARIN CORP PLC | $0 | – | -200,000 | -100.0% | -0.35% | – | |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -0.56% | – |
| NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -250,000 | -100.0% | -0.66% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -40,000 | -100.0% | -0.71% | – |
| Exit | EXELIXIS INC | $0 | – | -100,000 | -100.0% | -0.76% | – | |
| ALKS | Exit | ALKERMES PLC | $0 | – | -150,000 | -100.0% | -0.95% | – |
| TXG | Exit | 10X GENOMICS INC | $0 | – | -40,000 | -100.0% | -1.10% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -10,000 | -100.0% | -1.10% | – |
| NVO | Exit | NOVO-NORDISK A Sadr | $0 | – | -55,000 | -100.0% | -1.46% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -7,000 | -100.0% | -1.53% | – |
| CHWY | Exit | CHEWY INCcl a | $0 | – | -100,000 | -100.0% | -1.65% | – |
| XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -100,000 | -100.0% | -1.71% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -125,000 | -100.0% | -1.80% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -25,000 | -100.0% | -2.53% | – |
| NVS | Exit | NOVARTIS A Gsponsored adr | $0 | – | -70,000 | -100.0% | -2.54% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -35,000 | -100.0% | -2.73% | – |
| EHC | Exit | ENCOMPASS HEALTH CORP | $0 | – | -115,000 | -100.0% | -3.24% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -170,000 | -100.0% | -4.45% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -115,000 | -100.0% | -4.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.